Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don’t just curb their desire to eat; for some, they also lead them to drink less alcohol.

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise benefits besides shedding pounds soon surfaced. One of those – that the medication changed drinking and smoking habits overnight – understandably piqued the interest

Alcohol is responsible for a significant portion of global disease and death, contributing to 2.6 million deaths annually. It plays a role in over 200 medical conditions, including liver disease, cardiovascular disease,

A recent study published in JAMA Psychiatry revealed that Ozempic (semaglutide), a medication commonly used for type 2 diabetes, may reduce alcohol cravings and consumption in adults with alcohol use disorder.